Growth Metrics

CapsoVision (CV) Current Assets (2024 - 2025)

CapsoVision recorded quarterly Current Assets of $16.7 million in Q4 2025, down 30.68% quarter-over-quarter from $24.0 million in Q3 2025, and up 12.27% year-over-year from $14.8 million in Q4 2024.

CapsoVision's Current Assets history runs 2 years deep, the most recent figure standing at $16.7 million for Q4 2025.

  • In Q4 2025, Current Assets rose 12.27% year-over-year to $16.7 million; the TTM figure through Dec 2025 stood at $16.7 million (up 12.27% YoY), while the FY2025 annual figure was $16.7 million, up 12.27% from the prior year.
  • Current Assets came in at $16.7 million for Q4 2025 at CapsoVision, down from $24.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $24.0 million in Q3 2025 to a low of $7.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 25.51 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.34 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 24.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 8.68 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 6.23 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.45 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 4.33 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.43 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.39 Bn
10 CapsoVision 167.59 Mn 157.48 Mn 1.95 Mn 16.67 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 16.67 Mn
Sep 30, 2025 24.05 Mn
Jun 30, 2025 7.80 Mn
Dec 31, 2024 14.85 Mn